Related Experiment Video
Updated: Feb 18, 2026

05:58
Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
4.6K
[Leukopenia - A Diagnostic Guideline for the Clinical Routine]
Deutsche Medizinische Wochenschrift (1946)
|November 18, 2017
Summary
Diagnosing leukopenia involves reviewing past blood counts and performing a peripheral blood smear. Prompt antibiotic treatment for agranulocytosis with fever is crucial to reduce mortality.
Area of Science:
- Hematology
- Internal Medicine
- Clinical Pathology
Background:
- Leukopenia, a decrease in white blood cells, has diverse causes.
- Assessing previous blood counts and other cell lines (red blood cells, platelets) aids in determining the origin of leukopenia, such as bone marrow production issues.
- A manual peripheral blood smear is critical for detailed analysis of leukocyte subgroups and identifying potential causes like dysplasia.
Purpose of the Study:
- To outline diagnostic approaches for leukopenia.
- To emphasize the importance of peripheral blood smear analysis in diagnosing leukopenia.
- To highlight the emergent nature of leukopenia with agranulocytosis and fever.
Main Methods:
- Review of patient's previous blood counts.
- Analysis of red blood cell and platelet counts.
- Manual peripheral blood smear examination.
- Assessment for signs of dysplasia.
- Monitoring for fever in patients with leukopenia.
Main Results:
- Bi- or pancytopenia suggests impaired bone marrow production.
- Peripheral blood smear provides crucial details on leukocyte subgroups and dysplasia.
- Leukopenia, particularly agranulocytosis accompanied by fever, indicates a life-threatening condition.
Conclusions:
- A comprehensive diagnostic approach including historical blood counts and peripheral smear analysis is essential for leukopenia.
- Prompt medical intervention with broad-spectrum antibiotics is mandatory for patients presenting with agranulocytosis and fever to prevent mortality.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.7K
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
15.6K